Sandbox reserved 1169

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 14: Line 14:
Binding of NTS to the binding site is enriched by <scene name='72/721539/Binding_pocket_surface/3'>charge complementarity</scene> between the positive NTS arginine side chains and the [https://en.wikipedia.org/wiki/Electronegativity electronegative] pocket. In addition, the C-terminus forms a <scene name='72/721539/Binding_site_charges/2'>salt bridge</scene> with R328. Only three out of eight [https://en.wikipedia.org/wiki/Hydrogen_bond hydrogen bonds] are made between the side chains of NTS and the receptor. Most of the interactions are [https://en.wikipedia.org/wiki/Van_der_Waals_force van der Waals] interactions. The binding pocket is partially capped by a [https://en.wikipedia.org/wiki/Beta_hairpin β-hairpin loop] at the proximal end of the receptor protein's N-terminus.<ref name="White"/>
Binding of NTS to the binding site is enriched by <scene name='72/721539/Binding_pocket_surface/3'>charge complementarity</scene> between the positive NTS arginine side chains and the [https://en.wikipedia.org/wiki/Electronegativity electronegative] pocket. In addition, the C-terminus forms a <scene name='72/721539/Binding_site_charges/2'>salt bridge</scene> with R328. Only three out of eight [https://en.wikipedia.org/wiki/Hydrogen_bond hydrogen bonds] are made between the side chains of NTS and the receptor. Most of the interactions are [https://en.wikipedia.org/wiki/Van_der_Waals_force van der Waals] interactions. The binding pocket is partially capped by a [https://en.wikipedia.org/wiki/Beta_hairpin β-hairpin loop] at the proximal end of the receptor protein's N-terminus.<ref name="White"/>
=== Hydrophobic Stacking ===
=== Hydrophobic Stacking ===
-
A major player in the transduction of the extracellular signal to the intracellular G protein is the <scene name='72/727765/Hydrogen_bonding_network/1'>hydrogen bonding network</scene> that links the bound hormone with the hydrophobic core of the neurotensin receptor. The carboxylate of L13 forms a hydrogen bond network with R327, R328, and Y324. The Y324, in turn, is brought into an orientation to make the formation of a <scene name='72/727765/Hydrophobic_stacking_4xee/1'>hydrophobic stacking</scene> network between F358, W321, A157, and F317 possible.<ref name="Krumm">PMID:23051748</ref> The conformational changes caused by this stacking allows for the signal to be moved from the extracellular binding site through the transmembrane helices of the receptor to the intracellular region activating the G protein.
+
A major player in the transduction of the extracellular signal to the intracellular G protein is the <scene name='72/727765/Hydrogen_bonding_network/1'>hydrogen bonding network</scene> that links the bound hormone with the [https://en.wikipedia.org/wiki/Hydrophobe hydrophobic] core of the neurotensin receptor. The carboxylate of L13 forms a hydrogen bond network with R327, R328, and Y324. The Y324, in turn, is brought into an orientation to make the formation of a <scene name='72/727765/Hydrophobic_stacking_4xee/1'>hydrophobic stacking</scene> network between F358, W321, A157, and F317 possible.<ref name="Krumm">PMID:23051748</ref> The conformational changes caused by this stacking allows for the signal to be moved from the extracellular binding site through the transmembrane helices of the receptor to the intracellular region activating the G protein.
== Sodium Binding Pocket ==
== Sodium Binding Pocket ==
-
Conserved across all class A GPCRs, a <scene name='72/727765/Gw5_na_pocket_final/2'>sodium ion-binding pocket</scene> is seen in the middle of TM2 helix. The ion is coordinated with a highly conserved D<sup>2.50</sup> and four other contacts with oxygen atoms. Some of these oxygen atoms are sourced from water molecules. In order for G-protein activation, a <scene name='72/721539/4xee_na_binding_pocket/1'>hydrogen bond network</scene> with T<sup>3.39</sup>, S<sup>7.46</sup> ,N<sup>7.49</sup> of the NPxxY motif, prevents the coordination of a Na<sup>+</sup>. <ref name="Krumm"/><ref name="Katritch">PMID:24767681</ref>
+
Conserved across all class A GPCRs, a <scene name='72/727765/Gw5_na_pocket_final/2'>sodium ion-binding pocket</scene> is seen in the middle of TM2 helix. The ion is coordinated with a highly conserved D<sup>2.50</sup> and four other contacts with oxygen atoms. Some of these oxygen atoms are sourced from water molecules. In order for G-protein activation, a <scene name='72/721539/4xee_na_binding_pocket/1'>hydrogen bond network</scene> with T<sup>3.39</sup>, S<sup>7.46</sup> ,N<sup>7.49</sup> of the NPxxY [https://en.wikipedia.org/wiki/Structural_motif motif], prevents the coordination of a Na<sup>+</sup>. <ref name="Krumm"/><ref name="Katritch">PMID:24767681</ref>
=== Allosteric Effects ===
=== Allosteric Effects ===
-
Sodium ions are a negative allosteric inhibitor to the binding of the neurotensin agonist to the binding site on the neurotensin receptor. D113 of the highly conserved D/RY motif and N365 of the highly conserved NPxxY motif form a substantial hydrogen bonding network with T156 and S362.<ref name="Krumm"/> This hydrogen bonding network prevents the incorporation of the sodium ion by collapsing upon itself and therefor filling the sodium binding pocket. W321 also works to inhibit the incorporation of the sodium ion by capping off the sodium binding pocket to not allow sodium to enter from the top. W321 uses van der Walls interactions with other amino acids in the binding pocket to place it in the conformation necessary to complete this task.
+
Sodium ions are a negative [https://en.wikipedia.org/wiki/Allosteric_regulation allosteric] inhibitor to the binding of the neurotensin [https://en.wikipedia.org/wiki/Agonist agonist] to the binding site on the neurotensin receptor. D113 of the highly conserved D/RY motif and N365 of the highly conserved NPxxY motif form a substantial hydrogen bonding network with T156 and S362.<ref name="Krumm"/> This hydrogen bonding network prevents the incorporation of the sodium ion by collapsing upon itself and therefor filling the sodium binding pocket. W321 also works to inhibit the incorporation of the sodium ion by capping off the sodium binding pocket to not allow sodium to enter from the top. W321 uses van der Walls interactions with other amino acids in the binding pocket to place it in the conformation necessary to complete this task.
==Clinical Relevance==
==Clinical Relevance==
-
NTSR1 is commonly expressed in various invasive cancer cell lines. It is prevalent in the colon cancer adenocarcinoma, but is not found in adult colon cell types. NTSR1 is also found in aggressive prostate cancer cells, but not epithelial prostate cells. In prostate cancer cells, binding of the NTS results in mitogen-activated protein kinase (PKB), phosphoinositide-3 kinase (PI-3K), epidermal growth factor receptor (EGFR), SRC, and STAT5 phosphorylation. These all result in increased DNA sythesis, cell proliferation, and survival.<ref name="Valerie">PMID:21903767</ref> <ref name="Kisfalvi">PMID:19679549</ref>
+
NTSR1 is commonly expressed in various invasive [https://en.wikipedia.org/wiki/Cancer cancer] cell lines. It is prevalent in the [https://en.wikipedia.org/wiki/Colorectal_cancer colon cancer] [https://en.wikipedia.org/wiki/Adenocarcinoma adenocarcinoma], but is not found in adult colon cell types. NTSR1 is also found in aggressive [https://en.wikipedia.org/wiki/Prostate_cancer prostate cancer] cells, but not [https://en.wikipedia.org/wiki/Epithelium epithelial] prostate cells. In prostate cancer cells, binding of the NTS results in [https://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase mitogen-activated protein kinase (PKB)], [https://en.wikipedia.org/wiki/Phosphoinositide_3-kinase phosphoinositide-3 kinase (PI-3K)], [https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor epidermal growth factor receptor (EGFR)], [https://en.wikipedia.org/wiki/Proto-oncogene_tyrosine-protein_kinase_Src SRC], and [https://en.wikipedia.org/wiki/STAT5 STAT5] phosphorylation. These all result in increased DNA sythesis, [https://en.wikipedia.org/wiki/Cell_growth cell proliferation], and survival.<ref name="Valerie">PMID:21903767</ref> <ref name="Kisfalvi">PMID:19679549</ref>
http://cancerres.aacrjournals.org/content/69/16/6539.full.pdf+html
http://cancerres.aacrjournals.org/content/69/16/6539.full.pdf+html

Revision as of 20:39, 29 March 2016

Neurotensin Receptor (Rattus norvegicus)

Neurotensin G-Protein Coupled Receptor

Drag the structure with the mouse to rotate

References

  1. Millar RP, Newton CL. The year in G protein-coupled receptor research. Mol Endocrinol. 2010 Jan;24(1):261-74. Epub 2009 Dec 17. PMID:20019124 doi:10.1210/me.2009-0473
  2. Gui X, Carraway RE. Enhancement of jejunal absorption of conjugated bile acid by neurotensin in rats. Gastroenterology. 2001 Jan;120(1):151-60. PMID:11208724
  3. Selivonenko VG. [The interrelationship between electrolytes and phase analysis of systole in toxic goiter]. Probl Endokrinol (Mosk). 1975 Jan-Feb;21(1):19-23. PMID:1173461
  4. Fang Y, Lahiri J, Picard L. G protein-coupled receptor microarrays for drug discovery. Drug Discov Today. 2004 Dec 15;9(24 Suppl):S61-7. PMID:23573662
  5. 5.0 5.1 White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, Grisshammer R. Structure of the agonist-bound neurotensin receptor. Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10. PMID:23051748 doi:http://dx.doi.org/10.1038/nature11558
  6. Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci. 1999 Jul;20(7):302-9. PMID:10390649
  7. 7.0 7.1 7.2 White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, Grisshammer R. Structure of the agonist-bound neurotensin receptor. Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10. PMID:23051748 doi:http://dx.doi.org/10.1038/nature11558
  8. Katritch V, Fenalti G, Abola EE, Roth BL, Cherezov V, Stevens RC. Allosteric sodium in class A GPCR signaling. Trends Biochem Sci. 2014 May;39(5):233-44. doi: 10.1016/j.tibs.2014.03.002. Epub , 2014 Apr 21. PMID:24767681 doi:http://dx.doi.org/10.1016/j.tibs.2014.03.002
  9. Valerie NC, Casarez EV, Dasilva JO, Dunlap-Brown ME, Parsons SJ, Amorino GP, Dziegielewski J. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation. Cancer Res. 2011 Nov 1;71(21):6817-26. doi: 10.1158/0008-5472.CAN-11-1646. Epub, 2011 Sep 8. PMID:21903767 doi:http://dx.doi.org/10.1158/0008-5472.CAN-11-1646
  10. Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res. 2009 Aug 15;69(16):6539-45. doi: 10.1158/0008-5472.CAN-09-0418. PMID:19679549 doi:http://dx.doi.org/10.1158/0008-5472.CAN-09-0418
Personal tools